Back
Institute of Biomedical Research Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
28
MRES
Institute of Biomedical Research
Last Price:
0.0100
Seasonality Move:
31.31%
Sell
22
NBY
NovaBay Pharmaceuticals
Last Price:
2.20
Seasonality Move:
-15.47%
Sell
28
Institute of Biomedical Research (MRES)
is a Sell
Is Institute of Biomedical Research a Buy, Sell or Hold?
- The current Institute of Biomedical Research [MRES] share price is $0.0066. The Score for MRES is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- MRES is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $2.21. The Score for NBY is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MRES Stock Price Chart
What is Institute of Biomedical Research's stock price today?
-
The Institute of Biomedical Research share price today is $0.0066
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRES is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $2.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
MRES Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 38.53 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.0082 - 0.0082) | Sell |
Bollinger Bands (100): | (0.0095 - 0.0095) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.38 | Sell |
Relative Strength Index (14 RSI): | 39.58 | Sell |
Chaikin Money Flow: | -55437 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.06 - 4) | Sell |
Bollinger Bands (100): | (2.75 - 4.97) | Sell |
MRES Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.01 | Sell |
20-day SMA: | 0.01 | Sell |
50-day SMA: | 0.01 | Sell |
200-day SMA: | 0.01 | Sell |
8-day EMA: | 0.01 | Sell |
20-day EMA: | 0.01 | Sell |
50-day EMA: | 0.01 | Sell |
200-day EMA: | 0.01 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.22 | Sell |
20-day SMA: | 2.59 | Sell |
50-day SMA: | 3.18 | Sell |
200-day SMA: | 7.3 | Sell |
8-day EMA: | 2.3 | Sell |
20-day EMA: | 2.66 | Sell |
50-day EMA: | 3.21 | Sell |
200-day EMA: | 14.04 | Sell |
Institute of Biomedical Research Earnings Growth & MRES Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.48 per share, an increase next quarter of $0.35 per share, an increase this year of $74.90 per share, and an increase next year of $5.60 per share.
Institute of Biomedical Research Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |